Concepedia

Israel Lowy

IL

Statistics

Publications

109

Citations

22.8K

H-Index

57

Active since

1980

Affiliations

Regeneron (United States)(Current)

The University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

Stanford University

Harvard University

Israel Lowy is an author at Regeneron (United States) specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

1980–2025

109

Publications

109

Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Harriet M. Kluger, Margaret K. Callahan et al. · New England Journal of Medicine · 2013 · 4.2K citations · Full text

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Julie R. Brahmer, Charles G. Drake, Ira Wollner et al. · Journal of Clinical Oncology · 2010 · 2.9K citations · Full text

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Richard E. Royal, Catherine Lévy, Keli Turner et al. · Journal of Immunotherapy · 2010 · 1.2K citations · Full text

, , +17

Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

Kimberly E Beck, Joseph Blansfield, Khoi Q. Tran et al. · Journal of Clinical Oncology · 2006 · 831 citations · Full text

1–5 of 109